Liukrena - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 17,653,460 | 19,825,093 | 20,974,514 | 31,619,372 | 33,579,612 | 39,512,273 | 46,754,991 | 51,257,126 |
| Profit before tax | 923,742 | 699,004 | 1,318,654 | 721,159 | 1,328,703 | 1,039,711 | 1,324,730 | 1,361,155 |
| Net profit | 799,605 | 609,635 | 1,136,352 | 622,373 | 1,159,145 | 883,631 | 1,132,644 | 1,156,088 |
| Equity | 4,634,232 | 4,208,867 | 4,345,219 | 3,967,591 | 4,326,737 | 4,410,368 | 4,743,012 | 4,999,100 |
| Liabilities | 3,397,394 | 4,352,700 | 5,720,970 | 7,484,808 | 9,193,747 | 8,610,455 | 8,382,160 | 9,883,498 |
| Non-current assets | 1,094,538 | 1,021,526 | 828,600 | 800,992 | 904,967 | 973,844 | 843,124 | 806,876 |
| Current assets | 6,937,088 | 7,537,210 | 9,235,033 | 10,648,680 | 12,612,912 | 12,044,577 | 12,279,659 | 14,073,112 |
| Total assets | 8,031,626 | 8,558,736 | 10,063,633 | 11,449,672 | 13,517,879 | 13,018,421 | 13,122,783 | 14,879,988 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,613,115 | 1,898,537 | 2,132,691 |
| Social insurance contributions | - | - | - | - | - | 117,783 | 132,230 | 129,403 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -25.5% | +12.3% | +5.8% | +50.8% | +6.2% | +17.7% | +18.3% | +9.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 10.0% | 7.1% | 11.3% | 5.4% | 8.6% | 6.8% | 8.6% | 7.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 17.3% | 14.5% | 26.2% | 15.7% | 26.8% | 20.0% | 23.9% | 23.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.5% | 3.1% | 5.4% | 2.0% | 3.5% | 2.2% | 2.4% | 2.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.2% | 3.5% | 6.3% | 2.3% | 4.0% | 2.6% | 2.8% | 2.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 1.0 | 1.3 | 1.9 | 2.1 | 2.0 | 1.8 | 2.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 723,008 | 1,101,394 | 1,170,668 | 1,756,632 | 1,865,534 | 2,195,126 | 2,609,576 | 3,029,972 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Liukrena - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-08-12 | 10.56 |
| 2026-06-16 | 2026-06-17 | 13044.99 |
| 2025-07-24 | 2025-08-12 | 3.02 |
| 2024-07-24 | 2024-08-01 | 3.11 |
| 2022-08-23 | 2022-08-25 | 624.26 |
| 2021-11-16 | 2021-11-22 | 59.88 |
Liukrena - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-14 | 2026-08-20 | 0.36 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Liukrena, UAB (code 166926779) is a Private Limited Liability Company active in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €51.26M and net profit of €1.16M, compared with €46.75M revenue and €1.13M net profit in 2024 and €39.51M revenue and €883.6K net profit in 2023. This shows steady growth in both turnover and earnings over the last three years. Revenue increased by 9.6% year on year in 2025 and by 29.7% over two years, while the profit margin remained stable at 2.3% in 2025 after 2.4% in 2024 and 2.2% in 2023. As of 2025, total assets stood at €14.88M, equity at €5.00M and liabilities at €9.88M. Key efficiency indicators were solid, with ROE at 23.1%, ROA at 7.8% and asset turnover at 3.44x. Revenue per employee reached €3.20M, indicating high productivity within the business.